CERO fundamentals
CERo Therapeutics Holdings, Inc. earnings per share and revenue
Estimated earnings per share for the next quarter are -5.96 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CERO earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise